Turn Expanding Intelligence into Faster, Confident Decisions
Life sciences organizations are navigating a period of profound change. Shifting disease risk profiles, margin pressure across healthcare systems, and new access models are forcing teams to rethink how they shape portfolios, prioritize indications, and bring therapies to market.
At the same time, intelligence signals are rapidly expanding—from clinical trials and regulatory updates to scientific literature, conference insights, and real-world evidence. For teams across competitive intelligence, market insights, and strategy, this session provides a practical framework to move from fragmented research to a connected, decision-driving capability.
